G49108TO
| Organisms | Evidence |
|---|---|
| Streptococcus pneumoniae | |
| Mus musculus (house mouse) | |
| Saccharomyces cerevisiae (brewer's yeast) | |
| Sus scrofa (pig) | |
| Rattus norvegicus (Norway rat) |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
| B4GALT1 | UDP-Gal |
|
R |
|
R | |
| B4GALT2 | UDP-Gal |
|
Benzyl-[beta] |
|
Benzyl-[beta] | |
| B3GALT2 | UDP-Gal |
|
Lemieux |
|
Lemieux | |
| B3GALT5 | UDP-Gal |
|
R |
|
R |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
| B4GALT4 | UDP-Gal |
|
[beta]-1-thio-p-Nitrophenyl |
|
[beta]-1-thio-p-Nitrophenyl | |
| B4GALT3 | UDP-Gal |
|
4-Me-lumbelyl-[beta] |
|
4-Me-lumbelyl-[beta] | |
| B4GALT4 | UDP-Gal |
|
[beta]-1-4-methyl-umbelliferyl |
|
[beta]-1-4-methyl-umbelliferyl | |
| B4GALT1 | UDP-Gal |
|
|
| UniProt ID | Protein Name | Reference | Source |
|---|---|---|---|
| Q9VXM5 | LD22609p | ||
| Q9W2E7 | Protein Rae1 | ||
| Q9W2U7 | LP18708p | ||
| Q9W3Q5 | Checkpoint suppressor 1-like, isoform A | ||
| Q9WJR5 | Endogenous retrovirus group K member 19 Pol protein | ||
| Q9WTI7 | Unconventional myosin-Ic | ||
| Q9WTL7 | Acyl-protein thioesterase 2 | ||
| Q9WTN3 | Sterol regulatory element-binding protein 1 | ||
| Q9WTN6 | Solute carrier family 22 member 21 | ||
| Q9WTQ0 | Protein kinase C theta type |
| Pathway Name | Organism |
|---|---|
| Antimicrobial peptides | Sus scrofa |
| Antimicrobial peptides | Rattus norvegicus |
| Antimicrobial peptides | Dictyostelium discoideum |
| Antimicrobial peptides | Bos taurus |
| Antimicrobial peptides | Canis familiaris |
| Antimicrobial peptides | Mus musculus |
| Antimicrobial peptides | Gallus gallus |
| Antimicrobial peptides | Homo sapiens |
| Antimicrobial peptides | Drosophila melanogaster |
| Antimicrobial peptides | Xenopus tropicalis |
RES 1b:b-dglc-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 35177603 | Functionally selective signaling and broad metabolic benefits by novel insulin receptor partial agonists | Wu M | 2022 Feb 17 |
|
| 35093192 | Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2 | Han P | 2022 Feb 17 |
|
| 35123651 | Cryo-ET of Env on intact HIV virions reveals structural variation and positioning on the Gag lattice | Mangala Prasad V | 2022 Feb 17 |
|
| 35308105 | Structure of the Pf12 and Pf41 heterodimeric complex ofPlasmodium falciparum6-cysteine proteins | Dietrich MH | 2022 Feb 16 |
|
| 35170962 | Termination of Poly-N-acetylglucosamine (PNAG) Polymerization with N-Acetylglucosamine Analogues | Morrison ZA | 2022 Feb 16 |
|
| 35452593 | Structural and functional impact by SARS-CoV-2 Omicron spike mutations | Zhang J | 2022 Feb 16 |
|
| 35173332 | Structure and receptor recognition by the Lassa virus spike complex | Katz M | 2022 Feb 16 |
|
| 35169121 | Broad ultra-potent neutralization of SARS-CoV-2 variants by monoclonal antibodies specific to the tip of RBD | Ma H | 2022 Feb 15 |
|
| 35169143 | HSL1 and BAM1/2 impact epidermal cell development by sensing distinct signaling peptides | Roman A | 2022 Feb 15 |
|
| 35108220 | Ultrapotent neutralizing antibodies against SARS-CoV-2 with a high degree of mutation resistance | Zou J | 2022 Feb 15 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025